Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Wenzler · SciRah

Researcher profile · Semantic Scholar

E. Wenzler

Share profile

E. Wenzler — researcher profile on SciRah

h-index: 27
Works: 105
Citations: 2,038

Most-cited papers

Inhaled Antibiotics for Gram-Negative Respiratory Infections
E. Wenzler, D. Fraidenburg, T. Scardina, L. Danziger
2016Clinical Microbiology Reviews126 citations Open access
Semantic Scholar
Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects
E. Wenzler, M. Gotfried, J. Loutit, Stephanie Durso +3 more
2015Antimicrobial Agents and Chemotherapy101 citations Open access
Semantic Scholar
Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogens.
E. Wenzler, Matthew F. Deraedt, A. Harrington, Larry H Danizger
2017Diagnostic microbiology and infectious disease89 citations
Semantic Scholar
Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales
X. Tan, Hwang Kim, K. Baugh, Yanqin Huang +5 more
2021Infection and Drug Resistance79 citations Open access
Semantic Scholar
Exploring Aztreonam in Combination with Ceftazidime-Avibactam or Meropenem-Vaborbactam as Potential Treatments for Metallo- and Serine-β-Lactamase-Producing Enterobacteriaceae
M. Biagi, T. Wu, Michelle Lee, Shitalben R. Patel +2 more
2019Antimicrobial Agents and Chemotherapy78 citations Open access
Semantic Scholar
Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat
David A. Butler, M. Biagi, X. Tan, S. Qasmieh +2 more
2019Current Infectious Disease Reports63 citations
Semantic Scholar
Severe Sepsis Secondary to Persistent Lysinibacillus sphaericus, Lysinibacillus fusiformis and Paenibacillus amylolyticus Bacteremia.
E. Wenzler, Kamal Kamboj, J. Balada-llasat
2015International Journal of Infectious Diseases63 citations Open access
Semantic Scholar
Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia
M. Biagi, A. Vialichka, M. Jurković, T. Wu +5 more
2020Antimicrobial Agents and Chemotherapy60 citations Open access
Semantic Scholar
An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia
E. Wenzler, Fei Wang, D. Goff, B. Prier +3 more
2017Clinical Infectious Diseases60 citations Open access
Semantic Scholar
Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists
E. Wenzler, Mira Maximos, T. Asempa, Lauren R. Biehle +2 more
2023Pharmacotherapy58 citations Open access
Semantic Scholar
Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia.
E. Wenzler, D. Goff, J. Mangino, Erica E. Reed +2 more
2016Diagnostic microbiology and infectious disease58 citations
Semantic Scholar
Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers
E. Wenzler, E. Ellis-Grosse, K. Rodvold
2017Antimicrobial Agents and Chemotherapy55 citations Open access
Semantic Scholar
Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole
M. Biagi, X. Tan, T. Wu, M. Jurković +4 more
2019Journal of Clinical Microbiology49 citations Open access
Semantic Scholar
Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae
Z. Bulman, F. Krapp, N. Pincus, E. Wenzler +4 more
2021mSystems46 citations Open access
Semantic Scholar
Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous Hemofiltration
E. Wenzler, Kristen L. Bunnell, S. Bleasdale, Scott T. Benken +2 more
2017Antimicrobial Agents and Chemotherapy46 citations Open access
Semantic Scholar
Multicenter Evaluation of an MIC-Based Aztreonam and Ceftazidime-Avibactam Broth Disk Elution Test
Harley T. Harris, L. Tao, E. Jacobs, Y. Bergman +8 more
2023Journal of Clinical Microbiology43 citations Open access
Semantic Scholar
Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia
M. Biagi, D. Lamm, K. Meyer, A. Vialichka +5 more
2020Antimicrobial Agents and Chemotherapy41 citations Open access
Semantic Scholar
Activity of aztreonam in combination with ceftazidime-avibactam against serine- and metallo-β-lactamase-producing Pseudomonas aeruginosa.
Michelle Lee, Taylor C. Abbey, M. Biagi, E. Wenzler
2020Diagnostic microbiology and infectious disease39 citations
Semantic Scholar
Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
E. Wenzler, David A. Butler, X. Tan, T. Katsube +1 more
2021Clinical Pharmacokinetics38 citations Open access
Semantic Scholar
The importance of pharmacokinetics and pharmacodynamics in antimicrobial drug development and their influence on the success of agents developed to combat resistant gram negative pathogens: A review
M. Palmer, Lauren J. Andrews, Taylor C. Abbey, Ashley Dahlquist +1 more
2022Frontiers in Pharmacology37 citations Open access
Semantic Scholar
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales.
P. Tamma, P. Harris, A. Mathers, E. Wenzler +1 more
2022Clinical Infectious Diseases35 citations
Semantic Scholar
Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach
R. Kullar, E. Wenzler, J. Alexander, Ellie J. C. Goldstein
2022Open Forum Infectious Diseases33 citations Open access
Semantic Scholar
Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection.
K. Bauer, Jessica Johnston, E. Wenzler, D. Goff +4 more
2017Anaerobe31 citations
Semantic Scholar
Telavancin: the long and winding road from discovery to food and drug administration approvals and future directions.
E. Wenzler, K. Rodvold
2015Clinical Infectious Diseases31 citations
Semantic Scholar
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
E. Wenzler, Patrick J. Scoble
2020Infectious Disease and Therapy30 citations Open access
Semantic Scholar
Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review
Luke S.P. Moore, M. Villegas, E. Wenzler, T. Rawson +3 more
2023Infectious Disease and Therapy28 citations Open access
Semantic Scholar
Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
Yanqin Huang, Amisha P. Rana, E. Wenzler, Egon A. Ozer +4 more
2021Journal of Antimicrobial Chemotherapy28 citations Open access
Semantic Scholar
Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study
S. Leekha, Gwen L. Robinson, Jesse T. Jacob, Scott K. Fridkin +28 more
2024BMJ Quality & Safety27 citations Open access
Semantic Scholar
Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.
J. Borjan, K. Meyer, R. Shields, E. Wenzler
2019International Journal of Antimicrobial Agents26 citations
Semantic Scholar
Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants
E. Wenzler, S. Bleasdale, M. Sikka, Kristen L. Bunnell +4 more
2018Antimicrobial Agents and Chemotherapy25 citations Open access
Semantic Scholar
Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections
E. Wenzler, D. Goff, R. Humphries, E. Goldstein
2017Infectious Disease and Therapy24 citations Open access
Semantic Scholar
Safety and Efficacy of Apixaban For Therapeutic Anticoagulation in Critically Ill ICU Patients with Severe COVID-19 Respiratory Disease
E. Wenzler, Monaz H Engineer, M. Yaqoob, Scott T. Benken
2020TH Open21 citations Open access
Semantic Scholar
Implementation and optimization of molecular rapid diagnostic tests for bloodstream infections
E. Wenzler, T. Timbrook, J. Wong, J. Hurst +1 more
2018American Journal of Health-System Pharmacy21 citations
Semantic Scholar
The Antimicrobial Stewardship Approach to Combating Clostridium Difficile
E. Wenzler, Surafel G. Mulugeta, L. Danziger
2015Antibiotics19 citations Open access
Semantic Scholar
Pharmacokinetics and Dialytic Clearance of Isavuconazole during In Vitro and In Vivo Continuous Renal Replacement Therapy
M. Biagi, David A. Butler, X. Tan, S. Qasmieh +7 more
2019Antimicrobial Agents and Chemotherapy18 citations Open access
Semantic Scholar
In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci
T. Wu, K. Meyer, A. Harrington, L. H. Danziger +1 more
2019Journal of Antimicrobial Chemotherapy18 citations
Semantic Scholar
A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia
M. Biagi, David A. Butler, X. Tan, S. Qasmieh +1 more
2019Antibiotics17 citations Open access
Semantic Scholar
Performance of ceftazidime/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms
E. Wenzler, Michelle Lee, T.-J. Wu, K. Meyer +5 more
2018Journal of Antimicrobial Chemotherapy15 citations Open access
Semantic Scholar
Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens
M. Biagi, A. Shajee, A. Vialichka, M. Jurković +2 more
2020Antimicrobial Agents and Chemotherapy14 citations Open access
Semantic Scholar
Multicenter evaluation of activity of aztreonam in combination with avibactam, relebactam, and vaborbactam against metallo-β-lactamase-producing carbapenem-resistant gram-negative bacilli
Lili Tao, Ashley Dahlquist, Harley T. Harris, Emily B Jacobs +3 more
2024Antimicrobial Agents and Chemotherapy13 citations Open access
Semantic Scholar
Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales.
M. Biagi, Michelle Lee, Tiffany Wu, Aisha Shajee +4 more
2022Diagnostic microbiology and infectious disease13 citations
Semantic Scholar
Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility
Taylor C. Abbey, A. Vialichka, Michele Jurkovic, M. Biagi +1 more
2022Microbiology spectrum13 citations Open access
Semantic Scholar
Inadequate Cerebrospinal Fluid Concentrations of Available Salvage Agents Further Impedes the Optimal Treatment of Multidrug-Resistant Enterococcus faecium Meningitis and Bacteremia
E. Wenzler, Alina Adeel, Tiffany Wu, Michele Jurkovic +5 more
2021Infectious Disease Reports13 citations Open access
Semantic Scholar
Efficacy of oritavancin alone and in combination against vancomycin-susceptible and -resistant enterococci in an in-vivo Galleria mellonella survival model.
K. Meyer, Matthew F. Deraedt, A. Harrington, L. Danziger +1 more
2019International Journal of Antimicrobial Agents13 citations
Semantic Scholar
BundlED Up: A Narrative Review of Antimicrobial Stewardship Initiatives and Bundles in the Emergency Department
Maressa Santarossa, Emily Kilber, E. Wenzler, Fritzie S. Albarillo +1 more
2019Pharmacy13 citations Open access
Semantic Scholar
Controversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials
E. Wenzler, J. Wong, D. Goff, Christopher A. Jankowski +1 more
2016Antibiotics12 citations Open access
Semantic Scholar
Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy
Lauren J. Andrews, Scott T. Benken, X. Tan, E. Wenzler
2020BMC Nephrology11 citations Open access
Semantic Scholar
AUC-Based Monitoring of Vancomycin: Closing the Therapeutic Window.
M. Biagi, David A. Butler, E. Wenzler
2019The Journal of Applied Laboratory Medicine11 citations Open access
Semantic Scholar
Clinical use of the polymyxins: the tale of the fox and the cat.
E. Wenzler, Kristen L. Bunnell, L. Danziger
2018International Journal of Antimicrobial Agents11 citations
Semantic Scholar
Pharmacokinetics of Telavancin at Fixed Doses in Normal-Body-Weight and Obese (Classes I, II, and III) Adult Subjects
Kristen L. Bunnell, M. Pai, M. Sikka, S. Bleasdale +3 more
2018Antimicrobial Agents and Chemotherapy11 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Biagi×12
Invite
M. Biagi — researcher profile on SciRah
L. Danziger×7
Invite
L. Danziger — researcher profile on SciRah
K. Rodvold×6
Invite
K. Rodvold — researcher profile on SciRah
David A. Butler×6
Invite
David A. Butler — researcher profile on SciRah

×6

Invite

K. Meyer — researcher profile on SciRah

Invite

X. Tan — researcher profile on SciRah

Invite

Z. Bulman — researcher profile on SciRah

A. Vialichka×5

Invite

A. Vialichka — researcher profile on SciRah

Invite

D. Goff — researcher profile on SciRah

Invite

T. Wu — researcher profile on SciRah

Michelle Lee×4

Invite

Michelle Lee — researcher profile on SciRah

M. Jurković×4

Invite

M. Jurković — researcher profile on SciRah